基因治疗基因心肌病的基因疗法:心脏病的分子医学
Shubham Sharma1, Chandu Sadasivan1, Yangfei Yan1
1Division of Cardiology, Department of Medicine, Faculty of Medicine and Dentistry, and Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Canada.
The Canadian journal of cardiology
|February 6, 2026
概括
基因检测对于诊断心肌病症至关重要. 基因疗法,包括基因编辑和传递载体,为治疗这些心脏病提供了有前途的精准医学方法.
科学领域:
- 心血管遗传学 心血管遗传学
- 分子医学是分子医学.
- 基因治疗 基因治疗
背景情况:
- 遗传改变是心肌病的主要原因.
- 基因检测现在是心肌病诊断的标准.
- 基因特异性疗法代表了精准医学的重大进步.
研究的目的:
- 为了审查心肌病的遗传基础.
- 探索基于基因治疗心肌病的进展.
- 讨论基因治疗方法和输送载体.
主要方法:
- 关于遗传性心肌病的当前文献的综述.
- 对基因疗法策略的分析:替代,沉默和基因组编辑 (CRISPR/Cas9,基础/主要编辑器).
- 对基因传递载体的评估:病毒 (AAV),病毒样颗粒和非病毒纳米颗粒.
主要成果:
- 基因编辑工具可以精确纠正突变.
- 先进的病毒和非病毒载体提高了基因传递效率和安全性.
- 反感性寡核酸为大型基因变异提供解决方案.
结论:
- 基因疗法在治疗心肌病症方面具有显著的前景.
- 目前正在进行的研究重点是优化基因治疗和输送系统.
- 个性化治疗策略正在推进高伤心肌病,扩张性心肌病和其他遗传性心脏病.
相关概念视频
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Mutation, Gene Flow, and Genetic Drift
64.5K
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.5K
What is Genetic Engineering?
80.3K
Overview
80.3K
Heart Failure VI: Adjunct Therapies
368
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
368
Cardiomyopathy II: Dilated Cardiomyopathy
575
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
575


